Kyongbo Pharmaceutical Co., Ltd

Kyongbo Pharmaceutical Co., Ltd (경보제약) is a South Korean company established on 1987.03.31, engaged in the manufacture and sale of active pharmaceutical ingredients and finished pharmaceuticals. It is presented within the Chong Kun Dang (CKD) group as the CHEMICAL arm contributing to human health and life through API and general pharmaceutical manufacturing. The company states it succeeded in developing Cefaclor domestically for the first time, obtained cGMP certification from the US FDA, Europe's EDQM, Japan's PMDA and China's CFDA for sterile injectable raw materials and 1st generic drugs, and exports cephalosporin antibiotics, hyperlipidemia treatments and anticancer drugs to about 30 countries with USD 85 million in exports. Since 2001 it has entered the finished drug business, launching products in anesthesia/pain, circulatory, digestive and antibiotic areas. Its representative is Kim Tae-young and it listed on 2015.06.29.

Kyongbo Pharmaceutical Co., Ltd was established on 1987.03.31 with the mission of contributing to human health and life. It states that it succeeded in developing Cefaclor domestically for the first time, with high-quality raw material development as its top goal. Through efforts to modernize drug manufacturing and quality control standards, it received cGMP certification from the US FDA, Europe's EDQM, Japan's PMDA and China's CFDA for producing sterile injectable raw materials and 1st generic drugs, positioning itself as a leading API manufacturer. It exports cephalosporin antibiotics, hyperlipidemia treatments and anticancer drugs to about 30 countries with USD 85 million in exports. Since 2001 it has entered the finished drug business, launching products in anesthesia/pain, circulatory, digestive and antibiotic areas. It listed on 2015.06.29. Within the Chong Kun Dang (CKD) group it is presented as the CHEMICAL arm for API and general pharmaceutical manufacturing.

A leading active pharmaceutical ingredient manufacturer and global company contributing to human health and life, aiming to become a first-class company supplying high-quality medicines.

• Cefaclor

• Cephalosporin antibiotics

• Hyperlipidemia treatments

• Anticancer drugs

• Anesthesia and pain products

• Circulatory system products

• Digestive system products

1. 1경보제약kbpharma.co.kr
2. 2경보제약kbpharma.co.kr
3. 3경보제약kbpharma.co.kr
4. 4Kyongbo Pharmaceutical Co.wikidata.org